JCR Pharmaceuticals Co., Ltd.

TSE:4552 Stock Report

Market Cap: JP¥79.3b

JCR Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 5/6

JCR Pharmaceuticals has a total shareholder equity of ¥56.5B and total debt of ¥23.3B, which brings its debt-to-equity ratio to 41.3%. Its total assets and total liabilities are ¥102.2B and ¥45.8B respectively. JCR Pharmaceuticals's EBIT is ¥7.5B making its interest coverage ratio -147.7. It has cash and short-term investments of ¥18.8B.

Key information

41.3%

Debt to equity ratio

JP¥23.30b

Debt

Interest coverage ratio-147.7x
CashJP¥18.76b
EquityJP¥56.47b
Total liabilitiesJP¥45.75b
Total assetsJP¥102.23b

Recent financial health updates

No updates

Recent updates

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Jul 12
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

May 22
JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Mar 18
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Feb 29
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Financial Position Analysis

Short Term Liabilities: 4552's short term assets (¥57.6B) exceed its short term liabilities (¥30.1B).

Long Term Liabilities: 4552's short term assets (¥57.6B) exceed its long term liabilities (¥15.6B).


Debt to Equity History and Analysis

Debt Level: 4552's net debt to equity ratio (8%) is considered satisfactory.

Reducing Debt: 4552's debt to equity ratio has increased from 17.8% to 41.3% over the past 5 years.

Debt Coverage: 4552's debt is well covered by operating cash flow (40%).

Interest Coverage: 4552 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.